Ivermectin News and Research

RSS
Ivermectin (22,23-dihydroavermectin B1a + 22,23-dihydroavermectin B1b) is a broad-spectrum antiparasitic medication. It is traditionally used against worms, but more recently found to be effective against mites and some lice too. Ivermectin is currently being used to help eliminate river blindness (onchocerciasis) in the Americas and stop transmission of lymphatic filariasis around the world.
Study identifies a host of agents with anti-SARS-CoV-2 potential

Study identifies a host of agents with anti-SARS-CoV-2 potential

Early administration of ivermectin could help reduce viral transmission in COVID-19 patients

Early administration of ivermectin could help reduce viral transmission in COVID-19 patients

Could Ivermectin be an effective antiviral against SARS-CoV-2?

Could Ivermectin be an effective antiviral against SARS-CoV-2?

COVID-19 pandemic highlights the risk of using systemic corticosteroids

COVID-19 pandemic highlights the risk of using systemic corticosteroids

Favorable clinical outcome for ivermectin in COVID-19 animal model

Favorable clinical outcome for ivermectin in COVID-19 animal model

Despite COVID-19 setbacks, WHO aims to eliminate lymphatic filariasis by 2030

Despite COVID-19 setbacks, WHO aims to eliminate lymphatic filariasis by 2030

FDA grants approval of nonprescription Sklice lotion to treat head lice infestations

FDA grants approval of nonprescription Sklice lotion to treat head lice infestations

Nasal spray formulation of ivermectin for COVID-19 shows promise in pigs

Nasal spray formulation of ivermectin for COVID-19 shows promise in pigs

New inhibitor of SARS-CoV-2 RNA translation

New inhibitor of SARS-CoV-2 RNA translation

Certain live-attenuated vaccines can prevent severe complications of COVID-19

Certain live-attenuated vaccines can prevent severe complications of COVID-19

New method spurs production of antibiotic or antiparasitic compounds in actinobacteria

New method spurs production of antibiotic or antiparasitic compounds in actinobacteria

Favipiravir has weak effect on SARS-CoV-2 and Hydroxychloroquine none at all in hamster model

Favipiravir has weak effect on SARS-CoV-2 and Hydroxychloroquine none at all in hamster model

Repurposing immunosuppressants to manage COVID-19

Repurposing immunosuppressants to manage COVID-19

Researchers receive $5 million to study two types of parasitic infection

Researchers receive $5 million to study two types of parasitic infection

New clinical trial to investigate the efficacy of ivermectin against COVID-19

New clinical trial to investigate the efficacy of ivermectin against COVID-19

Clinical trial launched to evaluate experimental COVID-19 therapies

Clinical trial launched to evaluate experimental COVID-19 therapies

French scientists suggest nicotinic agonists could treat COVID-19

French scientists suggest nicotinic agonists could treat COVID-19

The approved dose of ivermectin alone not useful in treating COVID-19

The approved dose of ivermectin alone not useful in treating COVID-19

Antiparasitic drug Ivermectin kills coronavirus in 48 hours

Antiparasitic drug Ivermectin kills coronavirus in 48 hours

Australian scientists identify possible coronavirus drug

Australian scientists identify possible coronavirus drug